Minerva Neurosciences Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$3.40

+0.00 (+0.00%)

As of Sep 28, 10:15 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 7 78%

Hold 2 22%

Sell 0 0%

Price Target

Analyst Price Target +18.5% upside

Low Target $3.03

Average Target $4.03

High Target $5.66

Current Price $3.40

Current
$3.40

Target
$4.03

$3.03 $4.03 avg $5.66

Scenario Analysis

Bear Case

$3.03

-10.9%

Low target

Base Case

$4.03

+18.5%

Avg target

Bull Case

$5.66

+66.5%

High target

Risk/Reward

6.1x

Highly favorable

Price in Context

52-Week High

$12.46

-72.7% from high

52-Week Low

$2.06

+64.9% from low

Target vs 52W High

$4.03

-67.7% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-3.3%
AMGN Amgen Inc	Hold	43	47%	$190.87	-54.4%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+138.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-16.9%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-89.8%
MRNA Moderna Inc	Hold	30	37%	$149.45	-24.2%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-65.3%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-43.4%